Association between resistin gene -420 C/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis

Acta Diabetol. 2013 Apr;50(2):267-72. doi: 10.1007/s00592-010-0247-8. Epub 2010 Dec 29.

Abstract

Epidemiological studies on the association between the single nucleotide polymorphism (SNP) at -420 C/G (rs1862513) in the human resistin gene (RETN) and the risk of type 2 diabetes mellitus (T2DM) are conflicting. In order to derive a more precise estimation of the association, a meta-analysis was conducted. Twelve studies with 5,935 cases and 5,959 controls were enrolled by searching the databases of Medline, EMBASE, and Cochrane. Summary odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. The heterogeneity and publication bias were investigated. The main analysis indicated no significant association [for allelic model: OR = 0.97 (0.92-1.03); for additive model: OR = 0.95 (0.83-1.09); for recessive model: OR = 0.98 (0.86-1.12); for dominant model: OR = 0.95 (0.88-1.04)]. Overall, no significant heterogeneity was found. Subgroup analysis by race and source of controls indicated no significant association. In conclusion, the current meta-analysis did not observe any association between the polymorphism of RETN -420 C/G and the risk of T2DM. The study may help us further understand the genetics of T2DM. However, larger and prospective studies are warranted to confirm this finding.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus, Type 2 / genetics*
  • Gene Frequency
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • MEDLINE
  • Polymorphism, Single Nucleotide / genetics*
  • Resistin / genetics*

Substances

  • Resistin